Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.

In Brief Spring 2024

  • American Gastroenterological Association

    American Gastroenterological Association

    The American Gastroenterological Association awarded $300,000 to support a Dana-Farber study into pancreatic ductal adenocarcinoma (PDAC), an aggressive disease that currently has limited and short-lasting treatment options. This funding will enable Jeffrey Patterson-Fortin, MD, PhD, to gain insights into how PDAC responds to immune-based therapies that could provide longer term benefit for patients.

    Continue Reading

  • Julie Wallace Bennett

    Julie Wallace Bennett

    With a $250,000 gift, Julie Wallace Bennett established the Peter Warren Fund for Pancreatic Research, in honor of her partner, Peter. Brian Wolpin, MD, MPH, the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber will lead this research.

    Continue Reading

  • The Cancer Couch Foundation

    The Cancer Couch Foundation

    The Cancer Couch Foundation has granted $225,000 to support the work of Daniel Abravanel, MD, PhD. The funds will drive Abravanel’s research on how drug resistance arises in metastatic breast cancer and foster the development of innovative strategies for improving treatments for patients with this challenging form of the disease.

    Continue Reading

  • Charles A. King Trust

    Charles A. King Trust

    The Charles A. King Trust Postdoctoral Research Fellowship Program, administered by Health Resources in Action, awarded grants totaling $412,400 to support studies into genetic and epigenetic changes that occur in cancer progression, with the goal of identifying new therapeutic targets.

    Continue Reading

  • Carol and Peter Clark

    Carol and Peter Clark

    Carol and Peter Clark made a $300,000 estate gift through their donor-advised fund and charitable remainder trust to support the Jimmy Fund. The Clark Family has long supported the Jimmy Fund through the Jimmy Fund WMass Classic golf tournament and other fundraising and volunteer activities.

    Continue Reading

  • The Crystal Family Charitable Foundation

    The Crystal Family Charitable Foundation

    The Crystal Family Charitable Foundation recently made a generous $200,000 gift to support a variety of research and patient care programs at Dana-Farber. The funds will drive innovative prostate and pancreatic cancer research while enhancing social services offered to pediatric patients and grieving families.

    Continue Reading

  • Dunkin’ Joy in Childhood Foundation

    Dunkin’ Joy in Childhood Foundation

    Dunkin’ Joy in Childhood Foundation made a grant of $200,000 to launch the Dogs for Joy program at Dana-Farber and the Jimmy Fund. This initiative provides in-residence dogs to pediatric patients, helping with tasks like motivating children to get out of bed for a walk or even demonstrating how to put on a hospital gown.

    Continue Reading

  • Eva and Erick Eigner

    Eva and Erick Eigner

    Eva and Erick Eigner have pledged to give and raise a total of $300,000 to further research led by Kimmie Ng, MD, MPH, in the Young-Onset Colorectal Cancer Center exploring the microbiome and the use of machine learning and artificial intelligence to identify risk factors, and to support the center’s patient and family forum.

    Continue Reading

  • Hope Scarves

    Hope Scarves

    Daniel Abravanel, MD, PhD, received $115,000 from Hope Scarves in 2023 to support his investigations on the evolution of metastatic breast tumors and the mechanisms they use to evade treatment. This work promises to help transform the treatment of the disease in years to come.

    Continue Reading

  • Innovation in Cancer Informatics

    Innovation in Cancer Informatics

    Innovation in Cancer Informatics awarded $224,000 to support investigations led by Sylvan Baca, MD, PhD, and Eliezer Van Allen, MD, into circulating tumor DNA (ctDNA). This research will analyze tumor features and aims to, for the first time, guide therapy selection in breast cancer with low levels of ctDNA.

    Continue Reading